BCR News Alert C.R. Bard (BCR) 169.10 12/25/2014 11:00:12

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
C.R. Bard (BCR) 169.10 $BCR

Fed's Patience Puts Bulls In A Hurry
Scott Martindale - Seeking Alpha - Tue Dec 23, 11:08AM CST
U.S. stocks found support once again last week and rallied on strong volume. Of course, the main catalyst was the FOMC policy statement on Wednesday that maintained its dovish language with a pledge of considerable time before raising the fed funds...
DEF: 38.15 (-0.96), NFO: 49.34 (-0.38), PNW: 69.59 (+1.41), UTHR: 130.22 (+2.40), ED: 66.91 (+0.90), IBB: 299.80 (+5.12), LUV: 41.66 (+0.68), IYZ: 29.52 (-0.18), LYB: 81.31 (-0.89), SPY: 207.77 (+0.02), IDU: 120.07 (+1.13), IYW: 106.52 (-0.41), IYK: 106.07 (-0.66), IYJ: 108.21 (-0.61), IYH: 144.69 (+0.58), BCR: 169.10 (-0.44), IYM: 83.15 (-0.74), IYC: 137.57 (-0.15), NXPI: 76.75 (+0.48), FUTY: 31.00 (+0.60), IYF: 91.09 (-0.41), IYE: 45.37 (-0.54), PYZ: 53.07 (+0.10), SHW: 264.55 (+1.46), KNOW: 69.79 (+0.15)

CR Bard Has Returned 16.2% Since SmarTrend Recommendation (BCR)
Comtex SmarTrend(R) - Fri Dec 19, 9:23AM CST
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on October 6th, 2014 at $148.49. In approximately 2 months, CR Bard has returned 16.18% as of today's recent price of $172.51.
BCR: 169.10 (-0.44)

AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 2:37PM CST
Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
BSX: 13.13 (+0.07), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)

CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 17, 3:55PM CST
CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues with its sturdy performance in the international markets.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44), ANGO: 19.19 (+0.33)

CR Bard (BCR) Faces Series of Lawuits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 16, 4:25PM CST
CR Bard Inc. (BCR) has been hit by a wave of product liability lawsuits over its faulty pelvic mesh products and defective vaginal-mesh implants, which could result in billions of dollars in damages.
BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), ENDP: 72.10 (+0.34), BCR: 169.10 (-0.44)

Jim Cramer: These Charts Prove It's Oil-and-Gas vs. Everything Else
at The Street - Tue Dec 16, 10:01AM CST
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
CAH: 82.07 (+0.15), WMT: 86.43 (-0.23), PDCO: 48.79 (-0.02), JACK: 78.82 (-0.17), CFR: 70.74 (+0.17), RCL: 82.36 (+0.16), TGT: 74.65 (-0.04), LOW: 67.51 (-0.43), MSFT: 48.14 (-0.31), HSIC: 137.87 (+0.15), REGN: 400.12 (+6.07), YUM: 72.79 (+0.11), SYK: 96.00 (-0.61), MU: 34.91 (-0.06), BCR: 169.10 (-0.44), MCK: 209.79 (+0.58), STX: 68.82 (+0.17), EW: 130.75 (+1.17), WLP: 128.71 (+0.94), UAL: 64.93 (+2.45), CELG: 109.60 (+3.48), CBRL: 138.16 (+0.46), AZO: 617.43 (-3.87), STE: 66.76 (+0.85), MRK: 57.46 (+0.25), MCD: 93.83 (-0.39), SHW: 264.55 (+1.46), BIIB: 340.89 (+5.13), BDX: 139.90 (+1.44), BMRN: 88.18 (+0.89), CCL: 45.39 (+0.09), MDT: 74.08 (+0.31), SNA: 139.09 (unch), JBLU: 15.50 (+0.21), ADBE: 74.74 (+0.36), HUM: 144.38 (-0.31), RFMD: 16.59 (+0.29), EBAY: 57.10 (-0.12), DPZ: 95.39 (-0.23), SRCL: 133.27 (-0.16), XLF: 24.95 (-0.04), ZMH: 114.11 (+0.64), CY: 14.61 (+0.26), HD: 103.56 (-0.20), ORLY: 193.95 (-1.11), DIS: 94.42 (-0.27), LLY: 70.16 (+0.42), BMY: 59.15 (-0.01), WDC: 113.11 (-0.18), PLKI: 55.50 (+0.01), HPQ: 40.54 (+0.18), FRGI: 56.97 (+0.47), DIN: 101.87 (-0.40), DRI: 58.42 (-0.09), CI: 104.23 (-0.08), ABC: 91.60 (+0.18), TJX: 67.87 (-0.25), JWN: 78.14 (-0.58), AVGO: 100.72 (-0.06)

The Best Of The Best: Top 7 Dividend Aristocrats
Sure Dividend - at Seeking Alpha - Mon Dec 15, 6:55PM CST
Over the past 3 months I have analyzed each of the 54 Dividend Aristocrats. The complete list of Dividend Aristocrats sorted by sector is included in the tables below: Basic Materials Consumer Goods Financials Health Care ...
MKC: 76.63 (-0.15), GPC: 107.62 (-0.21), CAH: 82.07 (+0.15), ED: 66.91 (+0.90), SYY: 40.59 (-0.11), WMT: 86.43 (-0.23), GWW: 256.98 (-0.82), PNR: 66.99 (-0.09), TGT: 74.65 (-0.04), ABBV: 66.21 (+1.86), LOW: 67.51 (-0.43), BCR: 169.10 (-0.44), TROW: 87.34 (-0.25), VFC: 74.63 (-0.01), FDO: 79.14 (-0.01), HRL: 53.08 (-0.17), MHFI: 90.70 (+0.34), ADP: 85.24 (+0.07), ADM: 53.11 (-0.06), SIAL: 137.16 (-0.01), MCD: 93.83 (-0.39), DOV: 74.20 (-0.28), CVX: 113.47 (-0.48), SHW: 264.55 (+1.46), BF.B: 90.41 (+0.40), MMM: 166.96 (+0.09), BDX: 139.90 (+1.44), CLX: 105.46 (-0.62), MDT: 74.08 (+0.31), KMB: 117.77 (-0.21), XOM: 93.78 (-0.81), CB: 104.37 (-0.07), PEP: 97.09 (-0.27), SWK: 97.36 (+0.04), JNJ: 104.59 (+0.31), T: 33.96 (-0.07), CINF: 52.18 (-0.19), PPG: 231.12 (+0.05), WAG: 76.67 (+0.16), APD: 148.58 (unch), ECL: 107.18 (-0.27), KO: 42.94 (-0.03), ABT: 45.70 (-0.02), HCP: 44.00 (-0.45), NUE: 49.33 (-0.22), EMR: 62.73 (-0.10), LEG: 42.40 (+0.19), BMS: 45.96 (-0.12), ITW: 97.11 (-0.10), CTAS: 79.86 (+0.22), PG: 93.14 (-0.15), BEN: 56.99 (-0.14), AFL: 61.94 (unch), CL: 70.47 (-0.53)

Dividend Aristocrat Overview: C. R. Bard, Inc.
Harvesting Dividends - at Seeking Alpha - Fri Dec 12, 8:01PM CST
About C. R. Bard C. R. Bard (NYSE: BCR ), headquartered in Murray Hill, New Jersey, develops medical technologies and medical devices for that helps patients manage a variety of diseases. The company had sales in 2013 of $3.05 billion, up 3.1%...
BCR: 169.10 (-0.44)

Judge advises Bard to settle mesh lawsuits
Seeking Alpha - at Seeking Alpha - Fri Dec 12, 7:14AM CST

BSX: 13.13 (+0.07), JNJ: 104.59 (+0.31), BCR: 169.10 (-0.44)

Global Cardiology Surgical & Interventional Cardiology Devices Market 2014-2020
M2 - Fri Dec 12, 2:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/kddzlk/cardiology) has announced the addition of the "Cardiology Surgical & Interventional Cardiology Devices Market - 2014-2020" report to their offering. The global market of cardiovascular surgical devices is expected to grow at CAGR of 9% from 2014 to 2020. The cardiovascular surgical devices market includes wide range of diagnostic and therapeutic devices which are used in surgery such as Imaging devices, cardiovascular stents, catheter, cardiac rhythm management devices, monitoring devices and conventional surgical tools. There are different types of cardiovascular surgeries for which different surgical approaches and devices are required. This report includes Coronary Artery Bypass Grafting (CABG), Transmyocardial Laser Revascularization (TMR), Heart Valve Repair or Replacement, Arrhythmia Treatment, Aneurysm Repair, Heart Transplant and Surgery to Place Ventricular Assist Devices or Total Artificial Hearts. Surgical approaches for these surgeries are Open-Heart Surgery, Off-Pump Heart Surgery and Minimally Invasive Heart Surgery. US is the largest market for the cardiovascular surgery devices with 46% of global share. Europe has captured 27% of market share in the cardiovascular surgery devices. APAC has largest growth in the market which mainly comes from China and Japan. Key Topics Covered: 1. Executive summery 2. Cardiac surgical devices market overview 3. Market determinants 4. Market segmentation 5. Cost analysis 6. Market strategies 7. Market share 8. Geography analysis 9. Patent Analysis 10. Corporate profiles - Abbott Cardiovascular - Boston Scientific Corp. - C.R. Bard, Inc. - Cook Medical - Medtronic. Inc - Toshiba Corp - Covidien - Biosense Webster, Inc. - Edwards Lifescience Corp. - Plc Medical Systems For more information visit http://www.researchandmarkets.com/research/kddzlk/cardiology
BSX: 13.13 (+0.07), BCR: 169.10 (-0.44), MDT: 74.08 (+0.31), MDSY: 3.35 (-0.05)

AngioDynamics (ANGO) Signs PICC Deal with HealthTrust - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 11, 3:50PM CST
AngioDynamics Inc. (ANGO) has entered into a strategic partnership with HealthTrust, covering AngioDynamics' PICC (peripherally inserted central catheter) products.
BCR: 169.10 (-0.44), VASC: 27.30 (+0.71), ANGO: 19.19 (+0.33), MMSI: 17.17 (+0.01)

C. R. Bard declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 3:23PM CST

BCR: 169.10 (-0.44)

Bard Declares Quarterly Dividend
Business Wire - Wed Dec 10, 3:05PM CST
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 22 cents per share on Bard's common stock. The current indicated annual dividend rate is 88 cents per share. The dividend is payable on February 6, 2015 to shareholders of record at the close of business on January 26, 2015.
BCR: 169.10 (-0.44)

CR Bard Up 14.1% Since SmarTrend Uptrend Call (BCR)
Comtex SmarTrend(R) - Wed Dec 10, 11:19AM CST
SmarTrend identified an Uptrend for CR Bard (NYSE:BCR) on October 6th, 2014 at $148.49. In approximately 2 months, CR Bard has returned 14.12% as of today's recent price of $169.46.
BCR: 169.10 (-0.44)

Allergan Leads The 20 Best Value Bond Trades With A Maturity Of 1 Year Or More
Donald van Deventer - at Seeking Alpha - Wed Dec 10, 11:17AM CST

BDX: 139.90 (+1.44), BCR: 169.10 (-0.44), AXP: 94.08 (+0.26), TMO: 126.79 (+0.13), WBK: 26.85 (+0.22), AMT: 100.75 (+0.10), C: 54.54 (+0.12), AMGN: 160.67 (+3.15), CELG: 109.60 (+3.48), MCO: 98.29 (+0.29), AGN: 210.12 (+0.95), T: 33.96 (-0.07), GS: 195.89 (+0.39), JPM: 62.48 (unch), GILD: 91.29 (+1.84), MMP: 85.74 (+0.15)

Becton, Dickinson-Aethon to Boost Medication Management - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 5:50PM CST
Per the deal, the integrated solution will combine Becton Dickinson and Company's (BDX) leading-edge BD Cato IV Workflow product with Aethon's MedEx medication delivery tracking system.
ABC: 91.60 (+0.18), BDX: 139.90 (+1.44), BCR: 169.10 (-0.44), MMSI: 17.17 (+0.01)

CR Bard Set to Possibly Rebound After Yesterday's Selloff of 1.49%
Comtex SmarTrend(R) - Tue Dec 09, 4:39PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $169.82 to a high of $171.53. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $171.44 on volume of 718,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.10 (-0.44)

SmarTrend Watching for Potential Rebound in Shares of CR Bard After 1.49% Loss
Comtex SmarTrend(R) - Tue Dec 09, 4:38PM CST
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $169.82 to a high of $171.53. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $171.44 on volume of 718,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BCR: 169.10 (-0.44)

The Cooper Companies Q4 Earnings, Revenues Lag; Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 05, 3:09PM CST
The Cooper Companies Inc (COO) reported fourth-quarter 2014 earnings of $1.95 per share, which missed the Zacks Consensus Estimates by 8 cents.
ABC: 91.60 (+0.18), BCR: 169.10 (-0.44), MMSI: 17.17 (+0.01), COO: 164.19 (+0.99)

Teleflex Partners with Premier to Expand Dialysis Portfolio - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 03, 4:50PM CST
Teleflex Inc (TFX), recently entered into a strategic partnership with Premier, Inc., a healthcare solutions organization, for the former's ARROW Dialysis Access portfolio.
BCR: 169.10 (-0.44), CFN: 59.18 (+0.04), COV: 103.35 (+0.57), TFX: 116.82 (+0.28)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 90

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 34

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 67

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 112

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
ACP's 1-for-4 Split Raises Price, Not Investor Value Yet

Updated Category News Views 84

Four ACP shares are about to become one, and the calculator crowd is liable to make a mountain out of a bookkeeping move. abrdn Income Credit Strategies Fund will execute a 1-for-4 reverse split before the opening bell on December 7, 2026. The quoted share price should rise by roughly four times, but the economic stake held by an investor does not magically get bigger...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading
GEYOTO’s RE+ Debut Shows Demand, Not Yet Scale Proof

Updated Category News Views 39

Desert-colored booths do not pay invoices, but a nearly sold-out stash of spare units is a lot more useful than the usual trade-show applause. GEYOTO’s first RE+ appearance, held November 17–19 at the Las Vegas Convention Center, produced the kind of early evidence a young energy-products brand needs: people stopped, handled the equipment, asked questions, made...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 268

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading

Top 5 Most Recently Viewed Articles

Future of Crypto: Brian Armstrong on Innovative Payment Solutions

Updated Category News Views 292

Coinbase's Vision for Payments in the Crypto World Brian Armstrong, the CEO of Coinbase Global Inc. (NASDAQ: COIN), is optimistic about the role of payments as a transformative use case within the cryptocurrency landscape. In a recent discussion, he articulated how he believes this sector will significantly evolve, particularly in terms of integrating stablecoins into...

Continue Reading
Veeva Basics Empowering Biotechs to Enhance Efficiency and Growth

Updated Category News Views 185

Veeva Basics Revolutionizes Biotech Operations In today's fast-paced biotech landscape, efficient operations are crucial. Veeva Systems (NYSE: VEEV) has introduced Veeva Basics, a solution now adopted by over 100 emerging biotechs. With this innovative approach, these companies can simplify and standardize their operations, allowing them to focus on what truly matters:...

Continue Reading
Exploring the Rise of Small-Cap Stocks: A 2024 Overview

Updated Category News Views 613

Small-Cap Stocks Lead 2024 Gains In the vibrant market of 2024, small-cap stocks have shined brighter than ever, showcasing remarkable performance that has left traditional blue-chip stocks in their wake. While larger, well-known companies often dominate discussions, smaller firms are making headlines with exhilarating returns. Remarkable Returns in the Market This year,...

Continue Reading
Ridge Street Capital Signs Significant Growth in Lending Sector

Updated Category News Views 206

Ridge Street Capital's Impressive Growth in Investment Lending Ridge Street Capital, a dynamic private lending firm, is celebrating a remarkable achievement in its operation, reporting over 150% growth from one year to the next. This impressive advancement marks the firm as a key player in investment property financing, primarily due to its tailored approach and...

Continue Reading
Kuehn Law Advocates for Sarepta Therapeutics Shareholders

Updated Category News Views 153

Kuehn Law Advocates for Sarepta Therapeutics Shareholders Kuehn Law, PLLC, a law firm dedicated to shareholder litigation, is reaching out to investors of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) regarding pressing concerns that have surfaced about the company's internal practices. Recent investigations suggest that certain officers and directors possibly did not uphold...

Continue Reading